Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Sussman

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Asthma and Allergy|August 25, 2021
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized TrialJonathan Corren, Sarbjit S Saini, Remi Gagnon, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbiditiesCarla M Davis, Lars Lange, Kirsten Beyer, et al.
The World Allergy Organization Journal|January 18, 2024
Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticariaChristine J Rubeiz, Ricardo Asero, Stephen Betschel, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Allergy, Asthma & Immunology Research|July 2, 2021
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous UrticariaPavel Kolkhir, Sabine Altrichter, Riccardo Asero, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic DermatitisChih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
Allergy|November 13, 2021
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension studyMarcus Maurer, Ana Giménez-Arnau, Jonathan A Bernstein, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus DocumentMelinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspectiveGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2025
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studiesAna Maria Giménez-Arnau, Robert Szalewski, Michihiro Hide, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Asthma and Allergy|August 25, 2021
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized TrialJonathan Corren, Sarbjit S Saini, Remi Gagnon, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbiditiesCarla M Davis, Lars Lange, Kirsten Beyer, et al.
The World Allergy Organization Journal|January 18, 2024
Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticariaChristine J Rubeiz, Ricardo Asero, Stephen Betschel, et al.
Nature Medicine|November 9, 2021
Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trialMartin Metz, Gordon Sussman, Rémi Gagnon, et al.
Allergy, Asthma & Immunology Research|July 2, 2021
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous UrticariaPavel Kolkhir, Sabine Altrichter, Riccardo Asero, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic DermatitisChih-Ho Hong, Melinda J Gooderham, Lorne Albrecht, et al.
Allergy|November 13, 2021
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension studyMarcus Maurer, Ana Giménez-Arnau, Jonathan A Bernstein, et al.
Journal of Cutaneous Medicine and Surgery|November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus DocumentMelinda J Gooderham, Chih-Ho Hong, Lorne Albrecht, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspectiveGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2025
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studiesAna Maria Giménez-Arnau, Robert Szalewski, Michihiro Hide, et al.
Pageof 7